On June 4, 2025, Immunic, Inc. held its annual stockholders' meeting where stockholders voted to approve an amendment to the 2019 Omnibus Equity Incentive Plan, increasing the share limit by 7 million to a total of 26,448,871 shares, and elected three new directors.